Guillaume Fond, MD, PhD

Extrapyramidal side effects have been identified as frequent side effects of antipsychotics in RCTs with highly selected subjects, but how common are they in nonselected samples? This national multicenter...

Cardiovascular diseases are the primary cause of mortality in individuals with schizophrenia, yet no study has yet explored the impact of metabolic syndrome on schizophrenia relapse. This study explored...

Medication nonadherence among schizophrenia patients is common, but also possibly modifiable. Learn about how a patient self-report instrument—the MARS—can be used to identify nonadherence in these patients.